lobbying_activities: 4026964

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts. Sortable columns (indexed): client_name, issue_code, filing_year, filing_uuid. Sorting on any other column returns HTTP 400 (2026-09-04, #697) — use ?sql= with your own ORDER BY if you need it.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	is_no_activity	is_termination	received_date
4026964	58c29588-60ac-4f2a-a551-01a94d6f3fb4	Q2	LIFE SCIENCES PENNSYLVANIA	401105511	LIFE SCIENCES PENNSYLVANIA	2026	second_quarter	MED	Life Sciences PA supports a robust NIH budget as well as opportunities for Pennsylvania to maintain its leadership role with continued collaborative grant support including the DOD, EDA and NSF. The NIH is the leading investor worldwide in basic scientific research. This funding supports the crucial first step in life sciences investment through discovery and understanding of human biology and physiology. Pennsylvania research institutions and small companies received more than $2 billion in NIH funding in 2023 and, in many cases, hold contractual agreements with the NIH. This research also leads to spin-out companies and technology transfer that perpetuate the cycle of innovation in the Commonwealth. This cut threatens continued research and development in potential treatments and cures for patients. Life Sciences PA joined Pennsylvania patients and researchers at the Rally for Medical Research encouraging Congress to support the highest possible appropriation increase recommended by the medical research community and to complete the FY2026 appropriations process in a timely manner to avoid additional disruptions to the life sciences ecosystem.	HOUSE OF REPRESENTATIVES,SENATE	0	0	2026-07-07T15:18:50-04:00